- Home
- Software
- asia middle east
- cancer risk
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Cancer Risk Software Available In Asia Middle East
4 software items found
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate ...
Manufactured by:CMR Naviscan Corporation based inCarlsbad, CALIFORNIA (USA)
A New Standard of Care in Early Breast Cancer Detection. Even when a mammogram is deemed negative, additional adjunctive tests, such as Molecular Breast Imaging (MBI), for women with dense breast tissue or who are considered high-risk for breast cancer should be considered. When a patient is determined to have dense breast tissue, or has a ...
by:Simulations Plus based inLancaster, CALIFORNIA (USA)
DILIsym is a sophisticated quantitative systems toxicology (QST) software designed to predict and elucidate drug-induced liver injury (DILI). This tool utilizes a middle-out, multi-scale modeling approach to simulate the complex biochemical and physiological interactions leading to liver toxicity. DILIsym integrates compound exposure with mechanisms of drug toxicity and inter-individual ...